Harvard Bioscience, Inc. (HBIO) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 29.7M |
| Enterprise Value | 65.36M |
| P/E Ratio | -3.68 |
| PEG Ratio | -0.09 |
| Price/Sales Ratio | 0.49 |
| Price/Book Ratio | 8.65 |
| Enterprise/Revenue | 0.93 |
| Enterprise/EBITDA | -21.85 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | September 30, 2026 |
| Profit Margin | -0.13 |
| Operating Margin | -0 |
| Return On Assets | -0.16 |
| Return On Equity | -1.3 |
| Revenue | 86.55M |
| Revenue/Share | 19.6 |
| Gross Profit | 45.88M |
| EBITDA | -46.52M |
| Net Income | -56.7M |
| Diluted EPS | -12.8 |
| Total Cash | 4.86M |
| Total Cash/Share | 1.06 |
| Total Debt | 44.29M |
| Total Debt/Equity | 8.68 |
| Current Ratio | 1.76 |
| Book Value Per Share | 1.12 |
| 52-Week Change | 59.21 |
| 52-Week High | 10.2 |
| 52-Week Low | 4 |
| Moving Average 50 Days | 8.26 |
| Moving Average 200 Days | 6.54 |
| Average Volume | 21,314 |
| Shares Outstanding | 4.55M |
| % Held by Institutions | 29.9 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
| Last Split Date | March 16, 2026 |